TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 122 filers reported holding TCR2 THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | – | 85 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 85 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 85 | -40.6% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 143 | -92.7% | 0.00% | – |
| Q1 2022 | $5,000 | -83.9% | 1,959 | -70.4% | 0.00% | – |
| Q4 2021 | $31,000 | +14.8% | 6,625 | +113.6% | 0.00% | – |
| Q3 2021 | $27,000 | -25.0% | 3,102 | +37.7% | 0.00% | – |
| Q2 2021 | $36,000 | -29.4% | 2,253 | -1.3% | 0.00% | – |
| Q1 2021 | $51,000 | +131.8% | 2,283 | +222.9% | 0.00% | – |
| Q4 2020 | $22,000 | +2100.0% | 707 | +2180.6% | 0.00% | – |
| Q3 2020 | $1,000 | – | 31 | +29.2% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 24 | -91.3% | 0.00% | – |
| Q1 2020 | $2,000 | -86.7% | 276 | -74.3% | 0.00% | – |
| Q4 2019 | $15,000 | +1400.0% | 1,074 | +1817.9% | 0.00% | – |
| Q3 2019 | $1,000 | – | 56 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $4,046,814 | 1.69% |
| MPM BioImpact LLC | 3,370,982 | $3,367,611 | 0.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,738,947 | $2,735,660 | 0.40% |
| Newtyn Management, LLC | 1,075,000 | $1,073,710 | 0.22% |
| HARBOR CAPITAL ADVISORS, INC. | 68,230 | $68,148 | 0.07% |
| Artal Group S.A. | 750,000 | $749 | 0.04% |
| Oasis Management Co Ltd. | 200,000 | $199,760 | 0.04% |
| Redmile Group, LLC | 731,379 | $730,501 | 0.03% |
| X-Square Capital, LLC | 31,919 | $32 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 68,035 | $67,953 | 0.01% |